RHUMBLINE ADVISERS - CELLULAR BIOMEDICINE GROUP I ownership

CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 41 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q4 2020$298,000
+3.5%
16,228
+3.2%
0.00%
Q3 2020$288,000
+7.5%
15,730
-12.2%
0.00%
Q2 2020$268,000
-4.6%
17,909
+1.0%
0.00%
-100.0%
Q1 2020$281,000
+2.2%
17,735
+4.6%
0.00%
Q4 2019$275,000
+12.2%
16,949
+3.0%
0.00%
Q3 2019$245,000
-13.1%
16,459
-3.5%
0.00%
-100.0%
Q2 2019$282,000
+8.9%
17,054
+13.7%
0.00%0.0%
Q1 2019$259,000
-4.8%
14,998
-2.5%
0.00%0.0%
Q4 2018$272,000
+45.5%
15,377
+49.2%
0.00%
Q3 2018$187,000
-10.1%
10,303
-3.3%
0.00%
Q2 2018$208,000
+39.6%
10,650
-15.5%
0.00%
Q1 2017$149,000
-5.7%
12,601
+4.7%
0.00%
Q4 2016$158,000
-25.5%
12,033
-17.7%
0.00%
-100.0%
Q3 2016$212,000
+22.5%
14,614
+1.5%
0.00%0.0%
Q2 2016$173,000
-13.5%
14,394
+54.7%
0.00%0.0%
Q4 2015$200,000
-31.3%
9,307
+20.2%
0.00%0.0%
Q2 2015$291,0007,7450.00%
Other shareholders
CELLULAR BIOMEDICINE GROUP I shareholders Q2 2019
NameSharesValueWeighting ↓
S. MUOIO & CO. LLC 52,468$964,0001.05%
Olympiad Research LP 54,795$1,007,0000.58%
Alpine Global Management, LLC 119,902$2,204,0000.45%
GABELLI & Co INVESTMENT ADVISERS, INC. 65,922$1,212,0000.19%
First Trust Capital Management L.P. 32,688$601,0000.17%
GLAZER CAPITAL, LLC 232,103$4,266,0000.15%
Walleye Capital LLC 105,000$1,930,0000.13%
Yakira Capital Management, Inc. 17,588$323,0000.08%
Dynamic Technology Lab Private Ltd 17,929$330,0000.05%
EQUITEC PROPRIETARY MARKETS, LLC 10,600$195,0000.05%
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders